N=1 Symptomatic vertebral RR=0.62 (95% CI 0.47-0.83) # 2/6572 36 m Non-vertebral # RR=0.86 (95% CI 0.75-0.98) NNT=58 Subgroup analysis in 80+ (n=1488) showed efficacy
N=1 Symptomatic vertebral # RR=0.62 (95% CI 0.47-0.83) 2/6572 36 m Non-vertebral # RR=0.86 (95% CI 0.75-0.98) NNT=58